173 related articles for article (PubMed ID: 26093732)
1. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
[TBL] [Abstract][Full Text] [Related]
2. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
3. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
4. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
5. Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening.
Asch WS; Bia MJ
Adv Chronic Kidney Dis; 2014 Jan; 21(1):106-13. PubMed ID: 24359993
[TBL] [Abstract][Full Text] [Related]
6. Post-renal transplant malignancies: Opportunities for prevention and early screening.
Turshudzhyan A
Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850
[TBL] [Abstract][Full Text] [Related]
7. Role of cytomegalovirus and Epstein-Barr virus in patients with de novo colon cancer after renal transplantation.
Adani GL; Baccarani U; Lorenzin D; Bresadola V; Currò G; Sainz M; Gropuzzo M; Montanaro D; Tulissi P; Risaliti A; Bresadola F
Tumori; 2006; 92(3):219-21. PubMed ID: 16869239
[TBL] [Abstract][Full Text] [Related]
8. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.
Zilinska Z; Sersenova M; Chrastina M; Breza J; Bena L; Baltesova T; Jurcina A; Roland R; Lackova E; Cellar M; Laca L; Dedinska I
Neoplasma; 2017; 64(2):311-317. PubMed ID: 28052685
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
11. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
12. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
14. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
15. Special malignancy pattern in Chinese renal transplantation recipients: a single center experience and literature review.
Sun Q; Li X; Cheng D; He Q; Chen J; Ji S; Liu Z
Asian Pac J Cancer Prev; 2011; 12(12):3347-51. PubMed ID: 22471478
[TBL] [Abstract][Full Text] [Related]
16. Urological malignancy after renal transplantation.
Besarani D; Cranston D
BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
[TBL] [Abstract][Full Text] [Related]
17. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
18. Kidney Transplant Recipients Have Higher Malignancy Prevalence Than Hemodialyzed Patients.
Pyrża M; Małyszko J; Głogowski T; Wieliczko M; Żebrowski P; Małyszko J
Transplant Proc; 2022 May; 54(4):972-975. PubMed ID: 35282885
[TBL] [Abstract][Full Text] [Related]
19. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of malignancy during chronic renal failure.
Matas AJ; Simmons RL; Kjellstrand CM; Buselmeier TJ; Najarian JS
Lancet; 1975 Apr; 1(7912):883-6. PubMed ID: 47534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
